[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"vascular-access-complications\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:vascular-access-complications":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,53],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":22,"studyType":23,"phases":4,"briefSummary":24,"conditions":25,"keywords":31,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":41,"lastUpdatePostDateStruct":42,"startDateStruct":45,"completionDateStruct":47,"leadSponsor":49,"locationsCount":52},"100640402","radial-access-data-in-vascular-interventions-registry-100640402",false,"NCT07614386","Radial Access Data in Vascular Interventions Registry","Radial Access Data in Vascular Interventions: A Prospective Observational Registry Study","RADIUS","Inclusion Criteria:\n\n* Age ≥18 years\n* Patients undergoing routine percutaneous vascular interventions via radial or ulnar artery access\n* Ability to provide informed consent\n\nExclusion Criteria:\n\n* Age \\\u003C18 years\n* Procedures performed without radial or ulnar artery access\n* Incomplete procedural or clinical data\n* Refusal to participate in the registry","ALL","18 Years",{"count":20,"type":21},20000,"ESTIMATED","1 Year","OBSERVATIONAL","The RADIUS study is a prospective observational registry designed to collect real-world data regarding radial and ulnar artery access in percutaneous vascular interventions. The study aims to evaluate procedural characteristics, access-site complications, procedural success, and short-term clinical outcomes associated with transradial and transulnar vascular access.\n\nPatients undergoing routine percutaneous vascular interventions via radial or ulnar artery access at Mersin Medical Park Hospital will be consecutively enrolled. Demographic, clinical, angiographic, procedural, and post-procedural data will be prospectively collected and analyzed.\n\nThe study was initially designed as a single-center registry; however, following Institutional Review Board (IRB) approval, expansion into a multicenter registry with participating centers is planned.\n\nThis study is observational in nature and does not involve any experimental treatment, device, or intervention beyond standard clinical care.",[26,27,28,29,30],"Radial Artery Occlusion","Radial Artery Spasm","Vascular Access Complications","Coronary Artery Disease","Peripheral Arterial Disease",[32,33,34,35,36,37,38,27,39],"Radial access","Ulnar access","Transradial intervention","Coronary angiography","Percutaneous coronary intervention","Vascular complications","Radial artery occlusion","Registry","RECRUITING","2026-06-18",{"date":43,"type":44},"2026-06-23","ACTUAL",{"date":46,"type":44},"2026-05-15",{"date":48,"type":21},"2031-05-20",{"name":50,"class":51},"Mersin Medicalpark Hastanesi","OTHER",1,{"id":54,"slug":55,"hasResults":11,"nctId":56,"briefTitle":57,"officialTitle":58,"acronym":59,"eligibilityCriteria":60,"healthyVolunteers":11,"sex":17,"minAge":22,"maxAge":4,"enrollmentInfo":61,"targetDuration":4,"studyType":63,"phases":64,"briefSummary":66,"conditions":67,"keywords":76,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":83,"lastUpdatePostDateStruct":84,"startDateStruct":86,"completionDateStruct":88,"leadSponsor":90,"locationsCount":52},"100588234","novel-medical-device-for-pharmacological-therapy-100588234","NCT06938750","Novel Medical Device for Pharmacological Therapy","A Pilot Study of a Novel Medical Device for Pharmacological Therapy: The SecHold Device","Sechold","Inclusion Criteria:\n\n* patients admitted to the intensive care unit\n* patients with authorization to take part in the study\n\nExclusion Criteria:\n\n* Patients with pre-existing medical conditions: Patients with diseases affecting coagulation, such as hemophilia or thrombocytopathies, could be excluded.\n* Active infection patients: Any patient with vascular access site infections or systemic infections may be excluded to avoid complications.\n* Inability to give informed consent: Patients who are unable to understand or consent to participate in the study.",{"count":62,"type":21},262,"INTERVENTIONAL",[65],"NA","Background: Different co-creation methods were used to design and prototype a new fixative device for multiple intravenous therapies with the ability to control and identify the pharmacological therapy administered to a patient. Objectives: To validate a newly created device for the reduction of complications related to the use of intravenous therapy Methods: A multidisciplinary team composed of eight professionals specializing in the field of critical care and an engineering professional in industrial design was responsible for collecting, evaluating, and materializing the ideas and needs arising from clinical practice in a device that met the standards of the same.",[68,69,28,70,71,72,73,74,75],"Vascular Access","Vascular Access Complication","Catheter Malfunction","Catheter Infection","Therapeutic Drug Management","Nurse","Nurse Based Care Management","Innovative Procedures",[77,78,79,80,81,82],"VASCULAR ACCESS","CATHETER","THERAPY","COMPLICATION","DEVICE","CENTRAL VASCULAR ACCESS","2025-04-14",{"date":85,"type":44},"2025-04-22",{"date":87,"type":44},"2023-01-20",{"date":89,"type":21},"2026-09-20",{"name":91,"class":51},"Fundacion Miguel Servet"]